| | |
| | |
| Clinical data | |
|---|---|
| Trade names | Dimer-X |
| Other names | 3-[[6-[[3-Carboxy-2,4,6-triiodo-5-(methylcarbamoyl)phenyl]amino]-6-oxohexanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.030.771 |
| Chemical and physical data | |
| Formula | C24H20I6N4O8 |
| Molar mass | 1253.871 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Iocarmic acid (trade name Dimer-X) is a pharmaceutical drug used as an iodinated contrast medium for X-ray imaging in the 1970s and 80s. Uses included imaging of the uterus and fallopian tubes. It was applied in form of its salt, meglumine iocarmate. [1] [2]
It is not known to be marketed anywhere in the world in 2021.